This hypothesis is further supported by the presence of typical GBM genomic alterations (gain of Chr7, loss of Chr10 and 9p), as well as IDH wild‐type and unmethylated MGMT status associated with the upregulated PEG signatures. The gene discussed is MGMT; the disease is glioblastoma.